Advanced search
Publication Cover
Applied Economics Letters Volume 24, 2017 - Issue 4
Submit an article Journal homepage
553
Views
2
CrossRef citations to date
0
Altmetric
Articles

Who gets caught for corruption when corruption is pervasive? Evidence from China’s anti-bribery blacklist

Liming ZhouSchool of Economics, Zhejiang University, Hangzhou, China
,
Zhangfeng JinSchool of Economics, University of Nottingham Ningbo China, Ningbo, China
&
Zheng WangHull University Business School, Hull, UK;GEP, University of Nottingham, Nottingham, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6276-1831
ORCID Icon
Pages 258-263 | Published online: 14 May 2016

References

  • ABC News. 2014. “GlaxoSmithKline (GSK) Fined $488.8 Million for ‘Massive Bribery Network’ in China.” September 19.
  • Bai, C.-E., C.-T. Hsieh, and Z. Song. 2014. “Crony Capitalism with Chinese Characteristics.” Unpublished mimeo, University of Chicago Booth School of Business.
  • Cai, H., and D. Treisman. 2004. “State Corroding Federalism.” Journal of Public Economics 88 (3–4): 819–843. doi:10.1016/S0047-2727(02)00220-7.
  • Chen, Y., H. Li, and L.-A. Zhou. 2005. “Relative Performance Evaluation and the Turnover of Provincial Leaders in China.” Economics Letters 88 (3): 421–425. doi:10.1016/j.econlet.2005.05.003.
  • China Daily. 2011. “Many Doctors Dissatisfied with Pay, Work Conditions.” August 10.
  • China Daily. 2013. “Pharma Bribery Scandal in China Just the Tip of the Iceberg?” July 18.
  • Daily Mail. 2014. “China Fines Glaxosmithkline $492M for Bribery.” September 19.
  • Eberhardt, M., Z. Wang, and Z. Yu. 2015. “From One to Many Central Plans: Drug Advertising Inspections and Intra-National Protectionism in China.” Journal of Comparative Economics. Advance online publication. http://www.sciencedirect.com/science/article/pii/S0147596715000943.
  • Financial Times. 2013. “GSK is Test Case in China’s Rules Laboratory.” July 15.
  • Fisman, R., and J. Svensson. 2007. “Are Corruption and Taxation Reallyharmful to Growth? Firm Level Evidence.” Journal of Development Economics 83 (1): 63–75. doi:10.1016/j.jdeveco.2005.09.009.
  • Fisman, R., and Y. Wang. 2015. “The Mortality Cost of Political Connections.” Review of Economic Studies. Advance online publication. http://restud.oxfordjournals.org/content/early/2015/05/15/restud.rdv020.
  • Heilbrunn, J. R. 2000. “Anti-Corruption Commissions: Panacea or Real Medicine to Fight Corruption?” World Bank Institute Working Paper No. 37234. Washington, D.C.: The World Bank.
  • Jia, R., M. Kudamatsu, and D. Seim. 2015. “Political Selection in China: The Complementary Roles of Connections and Performance.” Journal of the European Economic Association 13 (4): 631–668. doi:10.1111/jeea.12124.
  • Jin, H., Y. Qian, and B. R. Weingast. 2005. “Regional Decentralization and Fiscal Incentives: Federalism, Chinese Style.” Journal of Public Economics 89 (9–10): 1719–1742. doi:10.1016/j.jpubeco.2004.11.008.
  • Lancet. 2013, July 13. “Doctors and Pharma in China.” The Lancet 382: 102. doi:10.1016/S0140-6736(13)61547-0.
  • Li, H., and L.-A. Zhou. 2005. “Political Turnover and Economic Performance: The Incentive Role of Personnel Control in China.” Journal of Public Economics 89 (9–10): 1743–1762. doi:10.1016/j.jpubeco.2004.06.009.
  • Qian, Y., and G. Roland. 1998. “Federalism and the Soft Budget Constraint.” American Economic Review 88 (5): 1143–1162.
  • Rand, J., and F. Tarp. 2012. “Firm-Level Corruption in Vietnam.” Economic Development and Cultural Change 60 (3): 571–595.
  • Sequeira, S., and S. Djankov. 2014. “Corruption and Firm Behavior: Evidence from African Ports.” Journal of International Economics 94 (2): 277–294.
  • Svensson, J. 2003. “Who Must Pay Bribes and How Much? Evidence from a Cross Section of Firms.” The Quarterly Journal of Economics 118 (1): 207–230. doi:10.1162/00335530360535180.
  • Xinhua Net. 2006. “Shangye Huilu Yicheng Pubian Xianxiang, Zhongyang Haoling 18 Buwei Lianshou Zhengzhi.” January 1. See an English recap of the report. http://www.wantchinatimes.com/news-subclass-cnt.aspx?id=20120809000077cid=1206.
  • Yang, Z., and D. Fan. 2012. “How to Solve the Crisis behind Bribegate for Chinese Doctors.” The Lancet 379 (9812): e13–e15. doi:10.1016/S0140-6736(11)60137-2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.